Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

YIT Corporation: Managers’ transactions – Heliövaara

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:02 a.m.YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Heliövaara, Eero Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_45 ____________________________________________

Wärtsilä publishes open access interactive map indicating potential of cost-optimal 100% renewable electricity systems

Wärtsilä Corporation, Trade press release, 6 May 2020 at 10 am EESTThe technology group Wärtsilä is today publishing on its website an extensive interactive map Atlas of 100% Renewable Energy on cost-optimal, 100% renewable electricity systems globally. The map provides valuable information on the potential of renewable energy in relation to geographical regions and their solar and wind conditions. Wärtsilä has modelled 145 countries and different regions of the world in one hour dispatch granularity to provide an illustrative guide as to the cost-optimal potential of developing 100%

YIT Corporation: Managers’ transactions – Kaukonen

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:00 a.m.YIT Corporation: Managers’ transactions – Kaukonen YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Kaukonen, Harri-Pekka Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_44

Correction: Terveystalo Group Interim report 1 January – 31 March 2020

The COVID-19 crisis impacts the business heavily in the short term Terveystalo Plc, Interim report, 6 May 2020 at 9:45 EESTIn the release published 6 May 2020 at 9:00 the full release attachment was missing from the English version. It is attached to this release.  This release is a summary of Terveystalo's Interim report 1 January – 31 March 2020. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/investors/Financial-information/. January–March 2020 in brief · Revenue decreased by 3.9 percent year-

NRC Group ASA - Appointed to a contract in Norway - NOK 39 million

Bane NOR has appointed NRC Bane AS, a company wholly owned by NRC Group ASA, to a power supply system contract on the railway connection between Alna and Etterstad. The contract is valued at approximately NOK 39 million and will involve rail services such as electro and groundwork. The work will commence in May 2020, and the project is scheduled for completion in January 2021. Closing date for submission of complaints is 10 days from today, and formal contractual signing can take place after this period at the earliest. For further information, please contact: Henning Olsen, CEO

C-RAD AB - Interim report January – March 2020

GROWTH AND POSITIVE RESULT DESPITE TURBULENT QUARTER FIRST QUARTER 2020      · Order intake amounted to 47.7 (47.8) MSEK, -3% in constant currencies · Order backlog amounted to 261.5 (201.2) MSEK · Revenue amounted to 51.8 (47.3) MSEK, corresponding to a 10% growth (7% in constant currencies) · Operating profit amounted to 1.0 (1.2) MSEK, corresponding to a margin of 1.9 (2.5) % · Net results after tax amounted 0.4 (0.8) MSEK · Result per share amounted to 0.01 (0.02) SEK Comments from Tim Thurn, CEO The first quarter of 2020 generated solid results, despite

Veoneer Begins Production of Technology Suite for Polestar 2

Stockholm, Sweden, May 6, 2020: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), launches its state-of-the-art suite of collision mitigation technology on the new fully electric Polestar 2.Veoneer begins production of its advanced sensing technology and software enabling the Polestar 2 to become a leader in the next generation of car safety. The system allows the Polestar 2 to gather information and data about its surroundings and the trajectory of vehicles around it to assist drivers to avoid potentially hazardous situations.  Key components of the

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2020

The first quarter of the year can be divided into two periods: before and after the COVID-19 outbreak in Europe. The year 2020 started well, with a strong order intake on the Swedish market as well as on our export markets - but since the corona virus hit us with force in the beginning of March, our export markets have stalled. The Swedish sales of ORGANOWOOD® timber and BIOkleen® maintenance products through retailers in the building and paint trade are still doing relatively well, while we are seeing increasing impact on the sales of OrganoTex® through sports and outdoor retailers. What

FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer. FDA grants orphan status to drugs intended to treat rare diseases affecting fewer than 200,000 people in the U.S. The orphan designation provides certain benefits to drug developers, including tax credits for clinical trial expenditures, waived user fees for marketing applications, and eligibility for

2020 Bulkers Ltd. (2020) Conversion of index-linked charter hire for Bulk Sandefjord and Bulk Sydney

Hamilton, Bermuda, May 6, 2020 2020 Bulkers has converted the index-linked charter hire for Bulk Sandefjord and Bulk Sydney to fixed rate charter hire from June to December 2020 at US$14,378 per day, gross, and US$14,702 per day, gross, respectively. The vessels will in addition earn a profit share based on the fuel cost saving generated by the scrubbers. Following the conversion, the six vessels in operation today have fixed rate charter coverage for 1,384 days remaining in 2020 at a weighted average rate of US$19,303 per day. The fixed charter hire coverage covers all budgeted G&A,

INTERIM REPORT 1 JANUARY – 31 MARCH 2020

First QUARTER Interim (1 January – 31 March 2020) · Net sales for the quarter amounted to MSEK 50 (81). · Operating profit/loss before depreciation and amortisation (EBITDA) was MSEK 26 (-232). · Operating profit/loss (EBIT) was MSEK 7 (-251). · Loss before tax amounted to MSEK -7 (-294). · Loss after tax totalled MSEK -7 (-288), corresponding to SEK -0.21 (-8.61) per share. · Operating cash flow was MSEK 8 (40). · Production from Own wind power operations was 124 GWh (103). The increase was due to stronger wind conditions than in the preceding year. · Average

First participant enrolled in the clinical hepatic impairment study with Mangoral

Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia”) today announced that the first participant has been enrolled in the company’s clinical study with Mangoral in volunteers with different degrees of hepatic impairment. Results from this hepatic study could potentially enable the use also in Mangoral’s target population with impaired liver function.The overall objective of this special populations hepatic study is to assess the influence of hepatic impairment on the safety, pharmacokinetics and pharmacodynamics of the liver specific oral MRI contrast agent, Mangoral. Patients with moderate or

Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction

6 May 2020 07:00 BST Farxiga approved in the US for the treatment of heart failurein patients with heart failure with reduced ejection fraction Farxiga is the first SGLT2 inhibitor proven to significantly reducethe risk of cardiovascular death and hospitalisation for heart failure AstraZeneca's Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D). The approval by the

Exel Composites' Business Review Q1 2020: Profitability improved; guidance withdrawn due to poor short term predictability

EXEL COMPOSITES PLC       STOCK EXCHANGE RELEASE       6 May 2020 at 09:00 EETQ1 2020 in brief · Order intake increased by 22.6% to EUR 34.5 million (Q1 2019: 28.2). · Revenue increased by 2.6% to EUR 27.8 million (27.1). · Adjusted operating profit increased to EUR 2.1 million (2.0), which is 7.5% of revenue (7.2). · Operating profit increased to EUR 1.9 million (0.4), which is 6.7% of revenue (1.5). · Earnings per share amounted to EUR 0.06 (-0.04).     Guidance for the full year 2020 (withdrawn) As a consequence of increased uncertainty and poor short term

Flexion Mobile strengthens China team

Former Unity business manager joins the successful Flexion teamLONDON, 6th of May, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has recruited Michael Hu to its China team. The former Unity business development manager brings many years of experience from the Chinese mobile game sector and will focus on growing Flexion's services and customer base in the Chinese market. "It is great to have Michael onboard. We want to be the go-to company for Chinese developers who look to distribute in the growing alternative distribution

Attendo's report for the first quarter of 2020 – Clear focus on moderating the effects of the Corona-virus

Attendo reports continued good organic growth and progress in the actions taken to regain profitability in existing operations. However, the first quarter of 2020 was overshadowed by the acute spread of the Corona-virus, which affects both Attendo’s customers and operations short-term. Since early March, Attendo has been taking powerful measures to moderate the effects of the virus.President and CEO Martin Tivéus comments on the report “The second half of the first quarter was clearly characterised by the ongoing coronavirus pandemic in all of our markets. A large percentage of our

OssDsign appoints VP of Sales for OssDsign USA, Inc to drive continued growth in the company’s largest market

OssDsign announces the appointment of Eric Patermo as VP of Sales for OssDsign USA, Inc, a wholly owned subsidiary of OssDsign AB. Eric will be responsible for further strengthening the company’s sales organisation in the United States with the aim to deliver continued strong growth.This appointment follows a period of very positive development for OssDsign in the United States since the IPO in May 2019. During this period, OssDsign resumed control of all commercial operations and strengthened the US organisation. The company has since reported strong consecutive quarterly growth and an

Interim report January – March 2020

First quarter: 1 January – 31 March 2020 · Revenues totalled EUR 10.5 million (9.0), a 16% increase. · Gaming revenues increased 19% to EUR 9.9 million (8.3). · Revenues from regulated markets were 94%. · Total active customers were 43,003 (35,219), an increase of 22%. · Deposits totalled EUR 33.3 million (26.5), a 25% increase. · Gaming margin amounted to 4.4% (4.6). · EBITDA was EUR 2.78 million (2.79), EBITDA margin was 26.5% (31.0). · EBIT was EUR 2.19 million (2.32), EBIT margin was 20.9% (25.7). · Net profit totalled EUR 2.16 million (2.30), net profit

Electrolux Professional AB interim report Q1 2020

First quarter, January – March 2020· Net sales amounted to SEK 2,091m (2,302). Sales decreased by 9.2%. Organically sales decreased by 13.7%. · EBITA amounted to SEK 221m (316), corresponding to a margin of 10.6% (13.7). · Operating income amounted to SEK 205m (301), corresponding to a margin of 9.8% (13.1). · Operating cash flow after investments amounted to SEK 16m (217). · Income for the period amounted to SEK 159m (241), and earnings per share was SEK 0.55 (0.84). · Net debt/EBITDA was 0.9x (0.8). · On March 23, 2020 Electrolux Professional was listed on Nasdaq

LeoVegas AB Q1: Quarterly report 1 January – 31 March 2020

“LeoVegas advocates for a sustainable gaming industry, responsible gaming and positive social development” – Gustaf Hagman, Group CEO FIRST QUARTER 2020: 1 januarY–31 marCH[[[1]]]  · Revenue increased by 4% to EUR 89.4 m (86.3). · EBITDA was EUR 9.0 m (7.2), corresponding to an EBITDA margin of 10.0% (8.3%). · The number of depositing customers was 413,269 (388,747), an increase of 6%. · The number of returning depositing customers was record-high 219,841 (200,040), an increase of 10%. · Earnings per share were EUR 0.02 (0.00) before and after dilution.

CONCENTRIC INTERIM REPORT JANUARY – MARCH 2020

FIRST QUARTER · Net sales: MSEK MSEK 456 (566) – sales were down –20% y-o-y. After adjusting for impact of currency (+2%), sales in constant currency were down –22%. · Operating income: MSEK 87 (126), generating an operating margin of 19.1% (22.2). · Earnings after tax: MSEK 60 (94); basic EPS of SEK 1.60 (2.43). · Cash flow from operating activities: MSEK 81 (102); cash generation affected by lower sales. · Group’s net debt: MSEK 27 (27); gearing ratio of 2% (2). President and CEO, David Woolley, comments on the Q1 2020 Interim Report.Market and sales developmentThe

Interim report for the period January 1 - March 31, 2020

Net sales amounted to SEK 14.1 million (22.5) attributable to deliveries within geothermal. During the first quarter, significant progress was made in Japan and in Iceland, despite travel bans and quarantine rules. Climeon also won a new maritime order from the cruise company Havila Voyages. Operating profit amounted to SEK -32.2 million (-16.7). The order backlog totaled SEK 778.8 million (799.3) at the end of the quarter. January - march ·Net sales amounted to SEK 14.1 million (22.5) ·Order intake amounted to SEK 15.4 million (0.0) ·Order backlog totaled SEK 778.8

Havnar Bjargingar Felag (Torshavn Rescue Association) on the Faroe Islands selects RescueRunner for their tough operations

Safe at sea’s RescueRunner is chosen by the Havnar Bjargingar Felag, the Rescue Association of Torshavn, on the Faroe Islands.  The RescueRunner will be an integral part of Havnar Bjargingar Felag’s rescue concept, for use in some of the world’s most remote and challenging waters.With inaccessible shorelines and rough seas, it is often difficult and dangerous to approach the shoreline too closely with larger lifeboats. To solve this challenge, Havnar Bjargingar Felag evaluated numerous possible systems and products available in the market only to chose Safe at Sea’s RescueRunner as the

There are no items matching the current filter
There are no more items matching the current filter
Back to top